ライフサイエンスコーパス: idiopathic Parkinson's disease

1 2) are the most common cause of familial and idiopathic Parkinson's disease.

2 ld improve postural control in patients with idiopathic Parkinson's disease.

3 nsation for dopamine loss in experimental or idiopathic Parkinson's disease.

4 ofile similar to that previously reported in idiopathic Parkinson's disease.

5 t the causative role of paraquat exposure in idiopathic Parkinson's disease.

6 pamine neurons is characteristic of advanced idiopathic Parkinson's disease.

7 ) has an increasing role in the treatment of idiopathic Parkinson's disease.

8 tation, and had typical clinical findings of idiopathic Parkinson's disease.

9 veries and to discuss their relationships to idiopathic Parkinson's disease.

10 tern of nigrostriatal dysfunction typical of idiopathic Parkinson's disease.

11 substitution at codon 2019 (Gly2019 ser), in idiopathic Parkinson's disease.

12 physiology of resting and postural tremor in idiopathic Parkinson's disease.

13 ut the Lewy body pathology characteristic of idiopathic Parkinson's disease.

14 e and a clinical syndrome closely resembling idiopathic Parkinson's disease.

15 diseases, including Alzheimer's disease and idiopathic Parkinson's disease.

16 ly indistinguishable from most patients with idiopathic Parkinson's disease.

17 lower than those reported for patients with idiopathic Parkinson's disease.

18 changes reminiscent of those which occur in idiopathic Parkinson's disease.

19 ciated with GBA mutations, and modestly with idiopathic Parkinson's disease.

20 he specific mutation (A53T) in a 40 cases of idiopathic Parkinson's disease, 3 cases of multisystem a

21 Twenty-one patients with idiopathic Parkinson's disease (46-76 years old, 11 male

22 pared to controls persisted in patients with idiopathic Parkinson's disease (after exclusion of all G

23 ganglia was investigated in 25 patients with idiopathic Parkinson's disease and 14 matched healthy co

24 A total of 17 patients with idiopathic Parkinson's disease and 16 age- and sex-match

25 20 patients with idiopathic Parkinson's disease and 21 healthy participan

26 e non-demented subjects with newly diagnosed idiopathic Parkinson's disease and 37 healthy matched co

27 movement have been studied in patients with idiopathic Parkinson's disease and age-matched healthy i

28 idal disorders: idiopathic torsion dystonia, idiopathic Parkinson's disease and Huntington's disease,

29 resynaptic dopamine storage in patients with idiopathic Parkinson's disease as a function of the cate

30 Eligible patients were aged 25-75 years, had idiopathic Parkinson's disease as measured by Queen Squa

31 en described with a phenotype much closer to idiopathic Parkinson's disease, but it does not appear t

32 how that fibroblasts from five patients with idiopathic Parkinson's disease can be efficiently reprog

33 Idiopathic Parkinson's disease can present with symptoms

34 d DJ-1 to be an abundant protein in control, idiopathic Parkinson's disease, cases with clinical and

35 gid syndromes of less than 5 years duration: idiopathic Parkinson's disease corticobasal degeneration

36 Differentiating idiopathic Parkinson's disease from atypical parkinsonia

37 Differentiation of idiopathic Parkinson's disease from MSA is important bec

38 esponses to clonidine clearly differentiated idiopathic Parkinson's disease from MSA-C and MSA-P.

39 ne/growth hormone (GH) testing distinguishes idiopathic Parkinson's disease from MSA.

40 ed 86 deceased older Catholic clergy without idiopathic Parkinson's disease from the Religious Order

41 Image-based classification for idiopathic Parkinson's disease had 84% sensitivity, 97%

42 se association between cigarette smoking and idiopathic Parkinson's disease has been reported in seve

43 The etiology of idiopathic Parkinson's disease (idPD) remains enigmatic

44 e, 26 female) cases were diagnosed as having idiopathic Parkinson's disease (IPD) and 70 (42 male, 28

45 lsy (PSP), multiple system atrophy (MSA) and idiopathic Parkinson's disease (IPD) can be clinically i

46 The accurate diagnosis of idiopathic Parkinson's disease (IPD) is not only importa

47 uptake (P = 0.0008) compared with a group of idiopathic Parkinson's disease (IPD) patients who had ba

48 y the role of neuronal complex 1 activity in idiopathic Parkinson's disease (IPD), expression of mito

49 essive neurodegenerative disorder similar to idiopathic Parkinson's disease (IPD).

50 ive losses of cardiac sympathetic neurons in idiopathic Parkinson's disease (IPD).

51 Postural instability (PI) is common in idiopathic Parkinson's disease (IPD).

52 opulation of 217 subjects, many of which had idiopathic Parkinson's disease (IPD).

53 Of these men, 92 subsequently developed idiopathic Parkinson's disease (IPD).

54 rlier in the cancer trajectory but rarely in Idiopathic Parkinson's Disease(IPD), Progressive Supranu

55 Interestingly, in idiopathic Parkinson's disease, iron homeostasis is alte

56 Idiopathic Parkinson's disease is a common neurodegenera

57 y syndrome, peduncular hallucinosis, treated idiopathic Parkinson's disease, Lewy body dementia witho

58 pars compacta of controls and subjects with idiopathic Parkinson's disease matched for age and postm

59 sed serum GH concentrations in patients with idiopathic Parkinson's disease (median increase 8.98 [IQ

60 re to differentiate individual patients with idiopathic Parkinson's disease, multiple system atrophy,

61 Multiple system atrophy and idiopathic Parkinson's disease patient groups had minima

62 The genetic epidemiology of late-onset idiopathic Parkinson's disease (PD) and 'parkin-proven'

63 peripheral lymphocytes of 43 newly diagnosed idiopathic Parkinson's disease (PD) cases and 62 age- an

64 ny compelling basis for a heritable basis of idiopathic Parkinson's disease (PD) has focused attentio

65 Idiopathic Parkinson's disease (PD) is an age dependent,

66 Idiopathic Parkinson's disease (PD) is an age-dependent,

67 loss of nigral dopaminergic (DA) neurons in idiopathic Parkinson's disease (PD) is believed to resul

68 Idiopathic Parkinson's disease (PD) is often accompanied

69 on of nigrostriatal dopamine (DA) neurons in idiopathic Parkinson's disease (PD) is still unknown.

70 The pathogenic mechanisms underlying idiopathic Parkinson's disease (PD) remain enigmatic.

71 or many years, visual hallucinations (VH) in idiopathic Parkinson's disease (PD) were thought to be a

72 atients with parkinsonian disorders: 86 with idiopathic Parkinson's disease (PD), 30 with progressive

73 sm, and through analysis of a subcohort with idiopathic Parkinson's disease (PD), we have demonstrate

74 py is important in supporting a diagnosis of idiopathic Parkinson's disease (PD).

75 en thought to have a role in the etiology of idiopathic Parkinson's disease (PD).

76 eus (STN) accompany movement difficulties in idiopathic Parkinson's disease (PD).

77 iseases such as Alzheimer's disease (AD) and idiopathic Parkinson's disease (PD).

78 ns, Lewy bodies, which are characteristic of idiopathic Parkinson's disease (PD).

79 uscles in the forearm of seven patients with idiopathic Parkinson's disease, studied with and without

80 Patients with idiopathic Parkinson's disease suffer not only from clas

81 tals, we randomly assigned 299 patients with idiopathic Parkinson's disease to undergo either pallida

82 ver study, 19 patients with mild-to-moderate idiopathic Parkinson's disease underwent functional magn

83 However, Lewy body pathology typical of idiopathic Parkinson's disease was found at autopsy in t

84 The GH response to clonidine in idiopathic Parkinson's disease was significantly differe

85 esting and postural tremors of patients with idiopathic Parkinson's disease were monitored using tran

86 Twenty-one patients with advanced idiopathic Parkinson's disease were studied.

87 l as significant reductions in patients with idiopathic Parkinson's disease, which correlates with th

88 -75 years, had been diagnosed with bilateral idiopathic Parkinson's disease with motor symptoms for m

89 To this end, 20 patients with idiopathic Parkinson's disease with subthalamic nucleus

90 d the effects of clonidine on 14 people with idiopathic Parkinson's disease (without autonomic defici

91 nucleus (STN DBS) improves motor symptoms in idiopathic Parkinson's disease, yet the mechanism of act